Growing community of inventors

Ibaraki, Japan

Keisaku Okada

Average Co-Inventor Count = 4.53

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 90

Keisaku OkadaKenjiro Mori (2 patents)Keisaku OkadaShuji Senda (2 patents)Keisaku OkadaAmane Mochizuki (1 patent)Keisaku OkadaShijun Zheng (1 patent)Keisaku OkadaLei Yu (1 patent)Keisaku OkadaSazzadur Rahman Khan (1 patent)Keisaku OkadaZheng Hou (1 patent)Keisaku OkadaKatsuyuki Okubo (1 patent)Keisaku OkadaKenjiro Minomi (1 patent)Keisaku OkadaChieko Kitaura (1 patent)Keisaku OkadaJian Liu (1 patent)Keisaku OkadaTakeshi Saika (1 patent)Keisaku OkadaYucheng Song (1 patent)Keisaku OkadaNatsuko Kagehisa (1 patent)Keisaku OkadaMasashi Kamiyama (1 patent)Keisaku OkadaKen Sato (1 patent)Keisaku OkadaKeisaku Okada (4 patents)Kenjiro MoriKenjiro Mori (21 patents)Shuji SendaShuji Senda (13 patents)Amane MochizukiAmane Mochizuki (118 patents)Shijun ZhengShijun Zheng (37 patents)Lei YuLei Yu (36 patents)Sazzadur Rahman KhanSazzadur Rahman Khan (23 patents)Zheng HouZheng Hou (17 patents)Katsuyuki OkuboKatsuyuki Okubo (15 patents)Kenjiro MinomiKenjiro Minomi (14 patents)Chieko KitauraChieko Kitaura (6 patents)Jian LiuJian Liu (6 patents)Takeshi SaikaTakeshi Saika (4 patents)Yucheng SongYucheng Song (3 patents)Natsuko KagehisaNatsuko Kagehisa (1 patent)Masashi KamiyamaMasashi Kamiyama (1 patent)Ken SatoKen Sato (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Nitto-denko Corporation (4 from 3,868 patents)


4 patents:

1. 8808879 - Phototherapy devices and methods comprising substituted carbazole compounds

2. 7442682 - Transepithelial delivery of peptides with incretin hormone activities

3. 6753190 - Immunologic test method and immunologic test kit

4. 6391652 - Immunoassay method and immunoassay kit

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…